Mandate

Vinge advised Investindustrial on its acquisition of Carl von Linnékliniken Group.

Carl von Linnékliniken Group is a leading fertility treatment clinic based in Uppsala offering various treatments such as IVF, IUI and gamete donation.

Investindustrial Growth Holdings S.à r.l. is an investment group with €11 billion of raised fund capital and focuses on taking control positions in medium-sized companies in Europe.

Vinge’s team consisted of responsible partner Matthias Pannier and associates Stina Bengtsson, Olivia Belding (M&A), Christoffer Nordin (Regulatory), Sofia Bergenstråhle (Intellectual Property), Veronika Garemark (Employment), Karl-Hugo Engdahl (GDPR) and Nathalie Hughes (Project Assistance).

 

Related

Vinge advises Axcel and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB

Vinge has advised Axcel VII and Accru Partners in connection with the acquisitions of Carlstedt & Lindh AB and Brahe Revisionsbyrå AB
April 24, 2025

Vinge advises Biotage in connection with RWK Bidco’s public tender

On 22 April 2025, RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, announced a public tender offer to the shareholders in Biotage AB to tender all ordinary shares in Biotage to RWK Bidco at a price of SEK 145 in cash per ordinary share.
April 22, 2025

Vinge advises Baseload Capital in connection with an investment from Google

Vinge has advised Baseload Capital Holding AB in connection with securing an investment from Google.
April 16, 2025